West Pharmaceutical Services | WST - Debt


West Pharmaceutical Services reported $202.8M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Align Technology USD 116.04M 1.6M Mar/2026
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Cerus USD 84.16M 791K Dec/2024
Charles River Laboratories USD 3.06B 485.84M Mar/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dentsply International USD 2.33B 137M Mar/2026
Haemonetics USD 1.22B 153K Mar/2026
ICU Medical USD 1.23B 94.6M Jun/2026
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
J&J USD 54.99B 7.05B Mar/2026
Medtronic USD 28.15B 192M Jun/2026
Merit Medical Systems USD 821.56M 9K Mar/2026
Neogen USD 793.3M 374K Dec/2025
OraSure Technologies USD 782K 465K Jun/2024
Quidel USD 2.87B 40.8M Mar/2026
Repligen USD 690.94M 144.36M Jun/2026
Solventum Corp USD 7.91B 97M Mar/2025
STAAR Surgical USD 37.29M 1.06M Mar/2026
Terumo JPY 379.8B 219.92B Mar/2026
Utah Medical Products USD 0 0 Mar/2022
West Pharmaceutical Services USD 202.8M 0 Mar/2026